Immunogen reported $-77005000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agios Pharmaceuticals AGIO:US USD -89109000 6.24M
Amgen AMGN:US USD 3.5B 62M
Astellas Pharma 4503:JP JPY 108.16B 38.67B
AstraZeneca AZN:LN USD 3.6B 404M
Bluebird Bio BLUE:US USD -85093000 14.32M
Bristol Myers Squibb BMY:US USD 5.32B 456M
Eli Lilly And LLY:US USD 2.31B 308.9M
Exelixis EXEL:US USD 88.28M 206K
Halozyme Therapeutics HALO:US USD 112.9M 66.29M
Immunogen IMGN:US USD -77005000 16.41M
Intrexon XON:US USD -5899000 15.79M
Karyopharm Therapeutics KPTI:US USD -30657000 12.1M
Macrogenics MGNX:US USD -22111000 16.82M
Nektar Therapeutics NKTR:US USD -34794000 9.48M
Novartis NVS:US USD 4.69B 34M
Pfizer PFE:US USD 10.52B 2.78B
Regeneron Pharmaceuticals REGN:US USD 1.33B 49.4M
Roche Holding ROG:VX 13.44B 2.56B
Seattle Genetics SGEN:US USD -175213000 59.32M